Advertisement

Advertisement

AU:NTI Stock Latest News

Neurotech clears secondary trading for new share issue

Company AnnouncementsNeurotech clears secondary trading for new share issue

Neurotech International Seeks ASX Quotation for 21.4 Million New Shares

PremiumCompany Announcements

Neurotech International Seeks ASX Quotation for 21.4 Million New Shares

20h ago

Neurotech to Highlight Paediatric Neurology Pipeline at NWR Virtual Healthcare Conference

PremiumCompany Announcements

Neurotech to Highlight Paediatric Neurology Pipeline at NWR Virtual Healthcare Conference

8d ago

Neurotech Flags Risks and Uncertainties in Neurodevelopmental Drug Strategy

PremiumCompany Announcements

Neurotech Flags Risks and Uncertainties in Neurodevelopmental Drug Strategy

13d ago

Neurotech Investors Back Capital Raisings and Director Participation at General Meeting

PremiumCompany Announcements

Neurotech Investors Back Capital Raisings and Director Participation at General Meeting

19d ago

Neurotech Narrows Half-Year Loss as Revenue Doubles

PremiumCompany AnnouncementsNeurotech Narrows Half-Year Loss as Revenue Doubles

1M ago

Neurotech’s NTI164 Shows Strong Long-Term Safety in Key Toxicology Study

Company Announcements

Neurotech’s NTI164 Shows Strong Long-Term Safety in Key Toxicology Study

1M ago

Neurotech International Calls March General Meeting, Moves to Digital Meeting Notices

Company Announcements

Neurotech International Calls March General Meeting, Moves to Digital Meeting Notices

2M ago

Neurotech Wins Ethics Approval for Pivotal Phase 3 Autism Trial of NTI164

PremiumCompany Announcements

Neurotech Wins Ethics Approval for Pivotal Phase 3 Autism Trial of NTI164

2M ago

Neurotech Advances Lead Paediatric Neurology Drug NTI164 with New FDA Designation, Data and Funding

PremiumCompany Announcements

Neurotech Advances Lead Paediatric Neurology Drug NTI164 with New FDA Designation, Data and Funding

2M ago

Neurotech’s NTI164 PANS Data Published in Leading Journal, Bolstering Paediatric Neuro Portfolio

PremiumCompany Announcements

Neurotech’s NTI164 PANS Data Published in Leading Journal, Bolstering Paediatric Neuro Portfolio

3M ago

Neurotech Issues New Shares, Affirms Regulatory Compliance

PremiumCompany Announcements

Neurotech Issues New Shares, Affirms Regulatory Compliance

3M ago

Neurotech Seeks ASX Quotation for 246.7 Million New Shares

PremiumCompany AnnouncementsNeurotech Seeks ASX Quotation for 246.7 Million New Shares

3M ago

Neurotech Director’s 5 Million Options Lapse, Reducing Potential Equity Exposure

Company Announcements

Neurotech Director’s 5 Million Options Lapse, Reducing Potential Equity Exposure

3M ago

Neurotech Options Lapse, Streamlining Capital Structure

Company Announcements

Neurotech Options Lapse, Streamlining Capital Structure

3M ago

Neurotech International Secures $4 Million to Advance Paediatric Neurological Treatments

PremiumCompany Announcements

Neurotech International Secures $4 Million to Advance Paediatric Neurological Treatments

3M ago

Neurotech International Initiates Trading Halt for Capital Raising Announcement

PremiumCompany Announcements

Neurotech International Initiates Trading Halt for Capital Raising Announcement

4M ago

Neurotech International’s AGM Reflects Strong Shareholder Support

PremiumCompany Announcements

Neurotech International’s AGM Reflects Strong Shareholder Support

4M ago

Neurotech Secures $4.73 Million R&D Tax Incentive for Clinical Advancements

PremiumCompany Announcements

Neurotech Secures $4.73 Million R&D Tax Incentive for Clinical Advancements

5M ago

Neurotech Expands NTI164 Access and Gains FDA Designation

PremiumCompany AnnouncementsNeurotech Expands NTI164 Access and Gains FDA Designation

5M ago

Neurotech International Announces 2025 Annual General Meeting

Company Announcements

Neurotech International Announces 2025 Annual General Meeting

5M ago

Neurotech International Releases 2025 Annual Report

Company Announcements

Neurotech International Releases 2025 Annual Report

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >